{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:48:36Z","timestamp":1784047716547,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T00:00:00Z","timestamp":1596931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>New markers of systemic lupus erythematosus (SLE) activity are under investigation. In recent years, the researchers have been focusing increased attention on the role of haematological indicators in assessing the disease activity. Specifically, neutrophil-, basophil-, eosinophil-, monocyte- and platelet-to-lymphocyte ratios (NLR, BLR, ELR, MLR and PLR) have been considered. The specific objective of this study was to determine the suitability of the haematological markers for the assessment of SLE activity and SLE-related organ damage. This study is a retrospective analysis of 136 patients with SLE (124 women and 12 men) who received chloroquine\/hydroxychloroquine (HQ\/HCQ) monotherapy or HQ\/HCQ therapy combined with low\/medium doses of glucocorticoid. All patients were assessed for disease activity using the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) scale. In addition, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) inflammatory parameters were determined in each patient. NLR, BLR, ELR, MLR and PLR were evaluated and correlated with the SLE activity parameters and inflammatory markers. The mean values of the haematological indicators were compared in particular manifestations of SLE-induced organ damage. For numerical variables, descriptive statistics were calculated: median, standard deviation, minimum and maximum values. The Mann\u2013Whitney <jats:italic>U<\/jats:italic> test was used for the comparison of continuous variables in the two groups. The Spearman rank correlation test was used to search for any relationships between variables. A <jats:italic>p<\/jats:italic> value\u00a0&lt;\u00a00.05 was considered to be statistically significant. We have found a positive correlation between ELR, MLR and the SLEDAI scale (<jats:italic>r<\/jats:italic>\u2009=\u20090.22 and <jats:italic>r<\/jats:italic>\u2009=\u20090.27, respectively). NLR, MLR and PLR ratios were significantly correlated with ESR and CRP. Considerably higher NLR values were found in patients with cutaneous and\/or mucosal symptoms and with kidney involvement compared to patients without such involvement (4.26\u2009\u00b1\u20094.2 vs 3.27\u2009\u00b1\u20092.7; <jats:italic>p<\/jats:italic>\u2009=\u20090.05 and 5.45\u2009\u00b1\u20095.6 vs 3.05\u2009\u00b1\u20092.0; <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001 respectively). BLR and MLR were significantly higher in patients manifesting symptoms of vasculitis (0.09\u2009\u00b1\u20090.1 vs 0.02\u2009\u00b1\u20090.01; <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001 and 3.1\u2009\u00b1\u20094.2 vs 0.3\u2009\u00b1\u20090.1; <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001 respectively), arthritis and\/or myositis (0.04\u2009\u00b1\u20090.09 vs 0.02\u2009\u00b1\u20090.01; <jats:italic>p<\/jats:italic>\u2009=\u20090.01 and 1.02\u2009\u00b1\u20092.6 vs 0.35\u2009\u00b1\u20090.4; <jats:italic>p<\/jats:italic>\u2009=\u20090.01 respectively), whereas elevated ELR ratios were observed in patients with vasculitis (0.4\u2009\u00b1\u20090.5 vs 0.08\u2009\u00b1\u20090.06; <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.001) compared to patients without such organ involvement. The PLR marker was substantially higher in patients exhibiting haematological disorders in the course of SLE (276.6\u2009\u00b1\u2009226.4 vs 192.6\u2009\u00b1\u2009133.5; <jats:italic>p<\/jats:italic>\u2009=\u20090.01). The results indicate that ELR and MLR are effective markers of SLE activity. The haematological indicators may predict SLE-dependent organ damage, particularly cutaneous, mucosal, arthritic, myositic, haematological and kidney involvement.<\/jats:p>","DOI":"10.1007\/s00296-020-04669-3","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T11:02:32Z","timestamp":1596970952000},"page":"1625-1629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8131-6709","authenticated-orcid":false,"given":"Dorota","family":"Suszek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0853-829X","authenticated-orcid":false,"given":"Anna","family":"G\u00f3rak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4345-1675","authenticated-orcid":false,"given":"Maria","family":"Majdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,9]]},"reference":[{"key":"4669_CR1","doi-asserted-by":"crossref","unstructured":"Jeleniewicz R, Suszek D, Majdan M (2015) Clinical picture of late-onset systemic lupus erythematosus in a group of Polish patients. Pol Arch Med Wewn 125(7\u20138):538\u2013544. https:\/\/www.mp.pl\/paim\/issue\/article\/2963","DOI":"10.20452\/pamw.2963"},{"key":"4669_CR2","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai A-M, Alarc\u00f3n GS, Gordon C et al (2012) Derivation and validation of Systemic Lupus International Collaborating Clinics (SLICC) classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473","journal-title":"Arthritis Rheum"},{"key":"4669_CR3","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R et al (2019) 2019 European league against Rheumatism\/American College of Rheumatology Classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71:1400\u20131412. https:\/\/doi.org\/10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"4669_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13075-015-0702-6","volume":"17","author":"J Mikdashi","year":"2015","unstructured":"Mikdashi J, Nived O (2015) Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research. Arthritis Res Ther 17:183. https:\/\/doi.org\/10.1186\/s13075-015-0702-6","journal-title":"Arthritis Res Ther"},{"key":"4669_CR5","doi-asserted-by":"crossref","unstructured":"Winthrop KL, Weinblatt ME, Bathon J, Burmester GR (2020) Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019. Ann Rheum Dis 79:88\u201393. https:\/\/ard.bmj.com\/content\/79\/1\/88","DOI":"10.1136\/annrheumdis-2019-216151"},{"issue":"393","key":"4669_CR6","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","volume":"8","author":"T D\u00f6rner","year":"2019","unstructured":"D\u00f6rner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 8(393):2344\u20132358. https:\/\/doi.org\/10.1016\/S0140-6736(19)30546-X","journal-title":"Lancet"},{"issue":"2","key":"4669_CR7","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3892\/etm.2018.6309","volume":"16","author":"Y Haitao","year":"2018","unstructured":"Haitao Y, Lili J, Liqiong Y, Chao G et al (2018) Predictive value of the neutrophil-to-lymphocyte ratio and hemoglobin in systemic lupus erythematosus. Exp Ther Med 16(2):1547\u20131553. https:\/\/doi.org\/10.3892\/etm.2018.6309","journal-title":"Exp Ther Med"},{"issue":"4","key":"4669_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3343\/alm.2019.39.4.345","volume":"39","author":"AY Gasparyan","year":"2019","unstructured":"Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M et al (2019) The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med 39(4):345\u2013357. https:\/\/doi.org\/10.3343\/alm.2019.39.4.345","journal-title":"Ann Lab Med"},{"key":"4669_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2018.07.008","author":"MS Wafaa","year":"2018","unstructured":"Wafaa MS, Nahed MS, Iman MG, Mohja A (2018) Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: relation with disease activity and lupus nephritis. Rheumatol Clin. https:\/\/doi.org\/10.1016\/j.reuma.2018.07.008","journal-title":"Rheumatol Clin"},{"key":"4669_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.kjms.2015.10.004","volume":"31","author":"C Zencir","year":"2015","unstructured":"Zencir C, Akpek M, Senol S, Selvi M et al (2015) Association between hematologic parameters and in-hospital mortality in patients with infective endocarditis. Kaohsiung J Med Sci 31:632\u2013638. https:\/\/doi.org\/10.1016\/j.kjms.2015.10.004","journal-title":"Kaohsiung J Med Sci"},{"key":"4669_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jsha.2015.02.004","volume":"27","author":"T Osadnik","year":"2015","unstructured":"Osadnik T, Wasilewski J, Lekston A, Strzelczyk J et al (2015) The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation. J Saudi Heart Assoc 27:144\u2013151","journal-title":"J Saudi Heart Assoc"},{"key":"4669_CR12","doi-asserted-by":"crossref","unstructured":"Koh CH, Bhoo-Pathy N, Ng KL, Jabir RS et al (2015) Utility of pre-treatment neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer 113:150\u2013158. https:\/\/www.nature.com\/articles\/bjc2015183","DOI":"10.1038\/bjc.2015.183"},{"issue":"1","key":"4669_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/0366-6999.221272","volume":"131","author":"XF Yang","year":"2018","unstructured":"Yang XF, Ding FM, Ye YC, Zhang SY (2018) Relationship between neutrophil-to-lymphocyte ratio and pulse wave velocity in young patients with systemic lupus erythematosus. Chin Med (Eng) 131(1):10\u201315. https:\/\/doi.org\/10.4103\/0366-6999.221272","journal-title":"Chin Med (Eng)"},{"issue":"6","key":"4669_CR14","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3233\/cbm-150534","volume":"15","author":"Z Lian","year":"2015","unstructured":"Lian Z, You-You X, Chong Z (2015) Application of platelet\/lymphocyte and neutrophil\/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer. Cancer Biomark 15(6):899\u2013907. https:\/\/doi.org\/10.3233\/cbm-150534","journal-title":"Cancer Biomark"},{"key":"4669_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00296-019-04274-z","volume":"39","author":"M Jaszczura","year":"2019","unstructured":"Jaszczura M, G\u00f3ra A, Grzywna-Rozenek E, Bar\u0107-Czarnecka M et al (2019) Analysis of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and mean platelet volume to platelet count ratio in children with acute stage of immunoglobulin A vasculitis and assessment of their suitability for predicting the course of the disease. Rheumatol International 39:869\u2013878. https:\/\/doi.org\/10.1007\/s00296-019-04274-z","journal-title":"Rheumatol International"},{"issue":"3","key":"4669_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3109\/14397595.2015.1091136","volume":"26","author":"B Qin","year":"2016","unstructured":"Qin B, Ma N, Tang Q, Wei T, Zhong R et al (2016) Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 26(3):372\u2013376. https:\/\/doi.org\/10.3109\/14397595.2015.1091136","journal-title":"Mod Rheumatol"},{"key":"4669_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.intimp.2016.04.006","volume":"36","author":"Y Wu","year":"2016","unstructured":"Wu Y, Chen Y, Yang X, Chen L et al (2016) Neutrophil-to-lymphocyte ratio (NLR) and platelet-to- lymphocyte ratio (PLR) were associated with disease activity in patients with\u00a0systemic lupus erythematosus. Int Immunopharmacol 36:94\u201399","journal-title":"Int Immunopharmacol"},{"key":"4669_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2018.07.008","author":"WM Soliman","year":"2018","unstructured":"Soliman WM, Sherif NM, Ghanima IM, El-Badawy MA (2018) Neutrophil to lymphocyte and platelet to lymphocyte ratios in\u00a0systemic lupus erythematosus: relation with disease activity and\u00a0lupus\u00a0nephritis. Reumatol Cl\u00edn. https:\/\/doi.org\/10.1016\/j.reuma.2018.07.008","journal-title":"Reumatol Cl\u00edn"},{"key":"4669_CR19","first-page":"11026","volume":"8","author":"L Li","year":"2015","unstructured":"Li L, Xia Y, Chen C, Cheng P et al (2015) Neutrophil\u2013lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study. Int J Clin Exp Med 8:11026","journal-title":"Int J Clin Exp Med"},{"key":"4669_CR20","doi-asserted-by":"publisher","first-page":"021","DOI":"10.5606\/archrheumatol.2017.5886","volume":"32","author":"AB Ayna","year":"2017","unstructured":"Ayna AB, Ermurat S, Co\u015fkun BN, Harman H et al (2017) Neutrophil to lymphocyte ratio and mean platelet volume as inflammatory indicators in systemic lupus erythematosus nephritis. Arch Rheumatol 32:021\u2013025. https:\/\/doi.org\/10.5606\/archrheumatol.2017.5886","journal-title":"Arch Rheumatol"},{"key":"4669_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22633","author":"J Yu","year":"2019","unstructured":"Yu J, Zeng T, Wu Y, Tian Y et al (2019) Neutrophil-to-C3 ratio and neutrophil-to-lymphocyte ratio were associated with disease activity in patients with\u00a0systemic lupus erythematosus. J Clin Lab Anal. https:\/\/doi.org\/10.1002\/jcla.22633","journal-title":"J Clin Lab Anal"},{"issue":"10","key":"4669_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/apm.12722","volume":"125","author":"Z Yang","year":"2017","unstructured":"Yang Z, Zhang Z, Lin F, Ren Y et al (2017) Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases. APMIS 125(10):863\u2013871. https:\/\/doi.org\/10.1111\/apm.12722","journal-title":"APMIS"},{"key":"4669_CR23","doi-asserted-by":"publisher","first-page":"105949","DOI":"10.1016\/j.intimp.2019.105949","volume":"76","author":"L Ma","year":"2019","unstructured":"Ma L, Zeng A, Chen B, Chen Y, Zhou R (2019) Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with systemic lupus erythematosus and their correlation with activity: a meta-analysis. Int Immunopharmacol 76:105949. https:\/\/doi.org\/10.1016\/j.intimp.2019.105949","journal-title":"Int Immunopharmacol"},{"key":"4669_CR24","doi-asserted-by":"publisher","first-page":"e1450","DOI":"10.6061\/clinics\/2020\/e1450","volume":"75","author":"L Wang","year":"2020","unstructured":"Wang L, Wang C, Jia X, Yang M, Yu J (2020) Relationship between neutrophil-to-lymphocyte ratio and systemic lupus erythematosus: a meta-analysis. Clinics (Sao Paulo) 75:e1450. https:\/\/doi.org\/10.6061\/clinics\/2020\/e1450","journal-title":"Clinics (Sao Paulo)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04669-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04669-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04669-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T23:20:09Z","timestamp":1628464809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04669-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,9]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4669"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04669-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,9]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}